The latest closing stock price for Organogenesis as of September 18, 2024 is 2.85.
An investor who bought $1,000 worth of Organogenesis stock at the IPO in 2019 would have $-788 today, roughly -1 times their original investment - a -22.78% compound annual growth rate over 6 years.
The all-time high Organogenesis stock closing price was 150.00 on January 11, 2019.
The Organogenesis 52-week high stock price is 4.71, which is 65.3% above the current share price.
The Organogenesis 52-week low stock price is 1.96, which is 31.2% below the current share price.
The average Organogenesis stock price for the last 52 weeks is 2.92.
An investor who bought $1,000 worth of Organogenesis stock at the IPO in 2019 would have $-788 today, roughly -1 times their original investment - a -22.78% compound annual growth rate over 6 years.
The all-time high Organogenesis stock closing price was 150.00 on January 11, 2019.
The Organogenesis 52-week high stock price is 4.71, which is 65.3% above the current share price.
The Organogenesis 52-week low stock price is 1.96, which is 31.2% below the current share price.
The average Organogenesis stock price for the last 52 weeks is 2.92.